US Stock MarketDetailed Quotes
SCPS Scopus BioPharma
- 0.000300
- +0.000200+200.00%
15min DelayClose Aug 23 16:00 ET
12.63KMarket Cap0.00P/E (TTM)
0.000300High0.000300Low6.90KVolume0.000300Open0.000100Pre Close2.07Turnover0.02%Turnover Ratio0.00P/E (Static)42.08MShares0.06800052wk High0.00P/B10.27KFloat Cap0.00000152wk Low--Dividend TTM34.22MShs Float47.860000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
Scopus BioPharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 64.90%-1.01M | 80.90%-759.86K | 28.87%-8.13M | 89.83%-421.9K | 66.16%-851.65K | -46.53%-2.88M | -42.22%-3.98M | -352.41%-11.42M | -351.28%-4.15M | -280.71%-2.52M |
| Net income from continuing operations | 11.77%-2.93M | 42.51%-2.68M | 56.54%-11.71M | 71.84%-1.84M | -35.58%-1.9M | 78.76%-3.32M | -36.87%-4.66M | -148.14%-26.95M | -520.31%-6.52M | -20.72%-1.4M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---1.46M | --0 | ---1.47M |
| Depreciation and amortization | -42.61%334 | -62.07%231 | 15.20%1.73K | -34.56%231 | -18.40%306 | 45.50%582 | 63.71%609 | 4.17%1.5K | -3.81%353 | 3.59%375 |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 95.36%13.47M | -44.74%143.53K | -61.57%86.59K |
| Change In working capital | 428.41%1.84M | 213.38%1.84M | 13.85%3.23M | -35.85%1.34M | 757.51%963.09K | -27.68%348.44K | 256.06%587.62K | 147.31%2.84M | 1,054.43%2.08M | -41.80%112.31K |
| -Change in prepaid assets | -40.75%66.06K | 116.86%65.61K | 76.55%-23.52K | -202.18%-159.83K | 181.37%413.87K | 164.03%111.5K | -69.41%-389.07K | -184.60%-100.31K | 314.81%156.42K | 428.59%147.09K |
| -Change in payables and accrued expense | 678.03%1.84M | 91.15%1.87M | 2.18%3.01M | -35.45%1.24M | 1,679.22%549.22K | -63.88%236.94K | 147.46%976.68K | 148.42%2.94M | 1,425.00%1.93M | -114.63%-34.78K |
| -Change in other current liabilities | ---68.28K | ---91.05K | --252.51K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 64.90%-1.01M | 80.90%-759.86K | 28.87%-8.13M | 89.83%-421.9K | 66.16%-851.65K | -46.53%-2.88M | -42.22%-3.98M | -352.41%-11.42M | -351.28%-4.15M | -280.71%-2.52M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 22.36%-1.55K | 0 | 0 | 0 | -1.55K | -2K | 0 | -2K |
| Net PPE purchase and sale | --0 | --0 | 22.36%-1.55K | --0 | --0 | --0 | ---1.55K | ---2K | --0 | ---2K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 22.36%-1.55K | --0 | --0 | --0 | ---1.55K | ---2K | --0 | ---2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -44.69K | 2.02M | -98.62%241.94K | -97.15%241.94K | 0 | 0 | 0 | 303.35%17.56M | 259.16%8.48M | -131.50%-104.51K |
| Net issuance payments of debt | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -104.77%-104.51K | --0 | ---- |
| Net common stock issuance | ---44.69K | --2.02M | --0 | --0 | --0 | --0 | --0 | 513.92%20.1M | 300.77%9.75M | --0 |
| Net other financing activities | ---- | ---- | 109.92%241.94K | ---- | ---- | ---- | ---- | -119.63%-2.44M | -58.45%-1.27M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---44.69K | --2.02M | -98.62%241.94K | -97.15%241.94K | --0 | --0 | --0 | 303.35%17.56M | 259.16%8.48M | -131.50%-104.51K |
| Net cash flow | ||||||||||
| Beginning cash position | -64.74%1.4M | -98.43%124.58K | 333.54%7.94M | -91.44%310.82K | -81.53%1.16M | -51.85%3.97M | 333.54%7.94M | 4,885.71%1.83M | 763.64%3.63M | 731.21%6.26M |
| Current changes in cash | 63.35%-1.05M | 131.65%1.26M | -228.65%-7.89M | -104.15%-179.96K | 67.53%-851.65K | -45.12%-2.88M | -162.14%-3.98M | 235.45%6.13M | 200.42%4.33M | -696.72%-2.62M |
| Effect of exchange rate changes | -74.62%14.52K | 59.08%17.33K | 452.22%67.84K | 69.56%-6.29K | 205.59%6.01K | 534.54%57.23K | -46.21%10.89K | 39.98%-19.26K | 31.77%-20.65K | -66.14%-5.69K |
| End cash Position | -68.69%362.1K | -64.74%1.4M | -98.43%124.58K | -98.43%124.58K | -91.44%310.82K | -81.53%1.16M | -51.85%3.97M | 333.54%7.94M | 333.54%7.94M | 763.64%3.63M |
| Free cash flow | 64.90%-1.01M | 80.90%-759.86K | 28.87%-8.13M | 89.83%-421.9K | 66.19%-851.65K | -46.53%-2.88M | -42.27%-3.98M | -352.49%-11.43M | -351.28%-4.15M | -281.02%-2.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
